A. Rachel Leheny

CIK 1484729 · CHIEF EXECUTIVE OFFICER · last filed 2026-04-07

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$114.4K

Companies

4

Total Filings

26

Lifetime Open-Market Net

$914.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CALC CHIEF EXECUTIVE OFFICER 131,926 $0.87 $114.4K $85.1K 19 2026-04-07
CalciMedica, Inc. (SCPH) Delisted CHIEF EXECUTIVE OFFICER 197,154 $5.67 $1.12M $79.2K 3 2024-11-01
CalciMedica, Inc. (GRAY) Delisted Chief Executive Officer 356,989 $5.50 $1.96M $0 1 2023-03-22
Anthera Pharmaceuticals Inc (ANTH) Delisted Director 1,423,896 $750.0K 3 2010-10-04

Recent Filings · Page 3 of 3

26 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-05-18 CALC Buy (P) +1,000 $2.7K EDGAR
2023-05-10 CALC Grant (A) $0 EDGAR
2023-03-22 CalciMedica, Inc. (GRAY) Delisted Grant (A) +739,326 $0 EDGAR
2010-10-04 Anthera Pharmaceuticals Inc (ANTH) Delisted Grant (A) $0 EDGAR
2010-09-24 Anthera Pharmaceuticals Inc (ANTH) Delisted Buy (P) +250,000 $750.0K EDGAR
2010-03-05 Anthera Pharmaceuticals Inc (ANTH) Delisted Mixed +1,173,896 $3.76M EDGAR
Showing 2126 of 26
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.